Our history of more than 250 years

Our history of more than 250 years SSP Co., Ltd.

SSP Co., Ltd. is a pharmaceutical company specializing in OTC (over-the-counter) drugs and healthcare products, providing a variety of products to meet health needs for more than 250 years since its establishment in 1765.

In 2017, the company became a member of the Sanofi Group, a global healthcare leader headquartered in Paris, France, which operates in more than 100 countries and creates, research, develops, and markets a wide range of medical solutions.
While SSP enjoys broad consumer support through its antipyretic analgesic "EVE," allergy medication " Alesion," L-cysteine vitamin " Hythiol," and sleep-improving drug " Drewell," the company will continue to contribute to improving people's health and quality of life through the development of high value-added pharmaceuticals such as "Switch OTC drugs" and the promotion of self-medication. For more information on SSP, please visit https://www.ssp.co.jp/.

1765 Founded as Minoya Yakubo in Yaesu, Tokyo by Shosuke Shirai
1940 Company name changed to SSP Co., Ltd.
1964 Narita Site opened in Narita-city, Chiba prefecture
1985 First to market ibuprofen as “EVE” OTC drug in Japan
2003 First to market sleep-improving drug as “Drewell" OTC drug in Japan
2011 First to market epinastine hydrochloride as “Alesion” OTC drug in Japan
2017 Joined the Sanofi Group as a result of the business exchange between Boehringer Ingelheim and Sanofi.
2024 Sanofi's Consumer Healthcare division was renamed 'Opella.'
2024 EVE released its first new product in seven years, “Eve Three Shot Premium.”

Related Links